friendlyone schreef op 9 maart 2015 15:27:
mailtje gestuurd naar Valeant heb onderstaande antwoord gekregen :
We have not yet closed the acquisition of Salix and I am not aware of the specific terms of the agreement with Pharming, but I do not believe we have any plans to change the relationship, which I would imagine is under contract.
Laurie
Sent: Monday, March 09, 2015 3:28 AM
To: Valeant Investor Relations; Little, Laurie
Subject: FW:
I am sorry I don't want to ask something that I don't may ask but can Valeant reassure the shareholders of Pharming please ?
--------------------------------------------------------------------------------
To:
laurie.little@valeant.com Subject:
Date: Mon, 23 Feb 2015 16:27:59 +0100
Hello,
First I want to congratulate you for your aquisition on Salix.
I have many shares of Pharming and Salix is a partner of Pharming for the selling of Ruconest.
Can you tell us please if this will continue now after this aquisition of Salix by your firm
Thank you for your kind respons